E-commerce business grows 186% at SenesTech (NASDAQ: SNES) in Q2
Rhea-AI Filing Summary
SenesTech, Inc. reported strong momentum in its e-commerce operations for the second quarter of 2026. The company said its active online subscription customer base, spanning both direct-to-consumer and business-to-business customers, more than doubled compared with the first quarter, reaching a record level and reinforcing its subscription-driven, recurring revenue model.
The company also stated that its e-commerce business grew 186% quarter over quarter, supported by investments in Amazon, SenesTech.com and its Shopify platform, including transitioning to direct management of these channels. Management highlighted that subscriptions for its Evolve® and ContraPest® rodent birth control products are designed to encourage ongoing product use and generate more predictable recurring revenue, with the strategy aimed at increasing customer lifetime value and strengthening long-term relationships across consumer and commercial markets.
Positive
- None.
Negative
- None.
Filing Explained
The update reports operating traction, but recurring-revenue and demand benefits remain prospective; March cash historically equaled 317.4 days of Q1 operating cash use.
The
Form 8-K reports specified material events, and this filing identifies Item 2.02 as results of operations and financial condition; it also states that the release is furnished and is not deemed filed under Section 18.
As of
Sources and calculations
- SenesTech Form 8-K and Exhibit 99.1 (2026-08-03)
- Form 8-K purpose (2026-08-03)
- SenesTech 2026 first-quarter fundamentals (2026Q1)
- Cash and equivalents vs quarterly operating cash outflow, in days of cash use $6,804,000 / ($1,929,000 / 90) = [object Object]
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
E-commerce business growth: 186%
1 metrics
E-commerce business growth
186%
Quarter-over-quarter growth during the second quarter of 2026
Key Terms
recurring revenue, customer lifetime value, direct-to-consumer, rodent birth control
4 terms
recurring revenue financial
"reinforces the Company's recurring revenue model while potentially increasing"
Revenue that a company expects to receive on a regular, predictable basis from ongoing sources such as subscriptions, service contracts, or repeat customer purchases. It matters to investors because it provides steadier cash flow and makes future earnings easier to forecast—like a landlord collecting monthly rent instead of one-off sales—supporting higher valuations and lower risk when those payments are reliable and customers tend to stay.
customer lifetime value financial
"potentially increasing customer lifetime value and improving long-term revenue"
Customer lifetime value is an estimate of how much money an average customer will bring to a business over the entire time they buy from it, after accounting for the cost to keep them. Investors use it like a long-term scorecard — higher lifetime value means each customer is more profitable and marketing or growth spending can be judged against the expected return, similar to planting a tree that produces fruit for years.
direct-to-consumer financial
"comprising both direct-to-consumer and business-to-business customers"
A direct-to-consumer (DTC) model is when a company sells its products or services straight to customers, skipping middlemen like retailers or wholesalers. For investors, DTC matters because it can mean higher profit margins, closer customer relationships and faster feedback—like a baker who sells directly from the shop instead of through a grocery chain—while also exposing the business to costs for marketing, customer support and logistics that affect growth and profitability.
rodent birth control technical
"leader in rodent birth control solutions"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did SenesTech (SNES) disclose about its e-commerce performance in Q2 2026?
SenesTech reported that its active online subscription customer base more than doubled in Q2 2026 versus Q1, and its e-commerce business grew 186% quarter over quarter, reflecting rapid adoption of its digital sales and subscription strategy.
How much did SenesTech (SNES) say its e-commerce business grew?
The company stated that its e-commerce business grew 186% during the second quarter of 2026 compared to the prior quarter. This growth was linked to stronger subscription uptake and investments in Amazon, SenesTech.com, Shopify and direct management of those online channels.
How is SenesTech (SNES) using subscriptions in its growth strategy?
SenesTech emphasized that building a larger active subscriber base is central to its long-term e-commerce strategy. Subscription customers are intended to generate predictable recurring revenue, improve visibility into future demand and deepen relationships for its Evolve® and ContraPest® rodent birth control products.
What role do B2B customers play in SenesTech’s (SNES) e-commerce channels?
SenesTech noted that a substantial portion of Shopify revenue comes from B2B customers, showing e-commerce demand extends beyond consumers. Smaller commercial accounts increasingly buy online, while larger accounts continue to be served by the company’s direct B2B sales team.
Which products does SenesTech (SNES) highlight in its subscription model?
The company highlighted its Evolve® and ContraPest® rodent birth control product lines within the subscription strategy. It said rodent birth control is designed for ongoing use, making subscriptions well suited to support long-term rodent population management programs and recurring revenue.
How does SenesTech (SNES) expect its e-commerce strategy to impact long-term growth?
Management stated that digital investments are intended to strengthen brands, expand recurring revenue and create opportunities across targeted commercial markets. As awareness of rodent birth control grows, SenesTech believes this e-commerce foundation will support sustainable growth and diversify its revenue base.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 3, 2026
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||
Registrant’s telephone number, including area code: (928 ) 779-4143
N/A | ||
(Former name or former address, if changed since last report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
The | ||||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On August 3, 2026, SenesTech, Inc. (the "Company") issued a press release discussing, among other things, the growth of its e-commerce business during the second quarter of 2026.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
The information contained in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except as may be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits.
| Exhibit Number | Exhibits | |||||||
| 99.1 | Press Release dated August 3, 2026. | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: August 3, 2026 | SENESTECH, INC. | |||||||
| By: | /s/ Thomas C. Chesterman | |||||||
| Thomas C. Chesterman | ||||||||
| Executive Vice President, Chief Financial Officer, Treasurer and Secretary | ||||||||
Exhibit 99.1
SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum
Integrated e-commerce strategy drives recurring revenue while supporting long-term growth across
consumer and business-to-business markets.
SURPRISE, Ariz., Aug. 3, 2026 — SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control solutions, today announced that its active online subscription customer base, comprising both direct-to-consumer ("DTC") and business-to-business ("B2B") customers, more than doubled during the second quarter of 2026 compared to the first quarter, reaching a record level. That expansion reinforces the Company's recurring revenue model while potentially increasing customer lifetime value and improving long-term revenue visibility.
SenesTech's e-commerce business, which serves DTC and B2B customers placing one-time and subscription orders, grew 186% during the second quarter compared to the prior quarter. Subscriber growth was a meaningful contributor. The growth also reflects the Company's investments in Amazon, SenesTech.com and digital marketing, as well as the transition to direct management of its Amazon channel and Shopify platform.
The Company's e-commerce channels are also a meaningful source of commercial demand. A substantial portion of Shopify revenue comes from B2B customers, which the Company believes demonstrates that e-commerce demand extends well beyond the consumer market. Smaller commercial accounts increasingly purchase directly online, while larger accounts continue to be served by the Company's direct B2B sales team.
The strategy serves multiple purposes. Beyond driving direct-to-consumer sales, the Company's digital investments are intended to increase brand awareness, educate the market about rodent birth control and generate demand that supports its direct B2B sales efforts. Management believes rising consumer awareness also strengthens commercial demand by expanding brand familiarity, supporting growth across the Company's targeted vertical markets.
Building a larger active subscriber base is a key element of the Company's long-term e-commerce strategy. Subscription customers help generate predictable recurring revenue, improve visibility into future demand and strengthen long-term customer relationships. Unlike one-time product purchases, subscriptions are expected to encourage ongoing product use and create a more stable, recurring revenue stream.
The Company believes this strategy is particularly well suited for both its Evolve® and ContraPest® product lines because rodent birth control is designed for ongoing use as part of a long-term rodent population management program rather than as a one-time treatment. A subscription model simplifies replenishment for both consumer and commercial customers while encouraging consistent product use.
"Subscriber growth has become one of the clearest indicators that our e-commerce strategy is working," said Michael Edell, President and Chief Executive Officer of SenesTech. "Every new subscriber strengthens the predictability and quality of our revenue while creating long-term customer relationships. And the investments we are making in e-commerce are benefiting our entire business."
"Our e-commerce strategy is only one component of our long-term growth plan," continued Edell. "The investments we are making today are strengthening our brands, expanding recurring revenue and creating opportunities across our targeted commercial markets. As awareness continues to grow, we believe this
foundation will support sustainable growth throughout our business and further diversify our revenue base over time."
About SenesTech, Inc.
SenesTech is the leader in rodent birth control solutions. The Company's patented products, marketed under its Evolve® and ContraPest® brands, provide effective, sustainable approaches to long-term rodent population management that can be integrated into existing pest management programs or used independently. SenesTech serves both consumer and professional markets with science-based solutions aimed at addressing one of the world's most persistent pest challenges.
For more information, visit https://senestech.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include, but are not limited to, statements regarding the expected benefits of the Company's e-commerce, direct-to-consumer, business-to-business and subscription strategies, including the potential for recurring customer relationships, increased customer lifetime value, future revenue visibility, future demand for Evolve® and ContraPest®, brand awareness and commercial growth. You are cautioned that such statements are based on current expectations and assumptions and are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the risk that the Company may not realize the benefits expected from its e-commerce, direct-to-consumer, business-to-business and subscription strategies, or be successful in the commercialization of its products, or realize sufficient market acceptance of its products, or capitalize on market opportunities and accelerate growth; risks related to the Company's financial performance, including the ability to fund its ongoing operations; risks related to required regulatory approvals for and regulation of the Company's products; and other factors and risks identified from time to time in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, the Company does not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
2